Dr Rozelle Kane

Dr Rozelle Kane MBBS MA MPhil(PHS) MRCGP is an NHS GP, healthcare innovator and keynote speaker specialising in artificial intelligence, digital healthcare safety and dementia diagnostics. Recognised for bridging the worlds of scientific research, frontline medicine and healthcare governance, Rozelle has become a respected voice on how healthcare systems can responsibly adopt emerging technologies. As Clinical Digital & Innovation Lead at Cambridgeshire and Peterborough NHS Foundation Trust and Co-Founder of EMBLA Risk Solutions, she works at the forefront of clinical AI assurance, helping organisations understand how technology can improve patient outcomes without compromising safety. Her work investigating blood biomarkers for dementia has positioned her within one of the most significant developments in modern medicine, the ability to detect diseases such as Alzheimer’s years before symptoms appear.

Rozelle’s career began with a deep academic interest in how medicine makes decisions and how those decisions can be improved. She initially trained in neuroscience and philosophy before qualifying in medicine, combining scientific thinking with a broader understanding of ethics, evidence and human behaviour. She later completed an MPhil researching blood biomarkers for dementia, examining the science behind earlier and more accurate detection of neurodegenerative disease. This research explored the growing potential for simple blood tests to transform dementia diagnosis and patient care, while also raising difficult questions around how healthcare systems and clinicians respond to earlier diagnoses. Alongside her research, Rozelle continued practising as an NHS GP, ensuring her work remained grounded in the realities of patient care and public health. Her unusual combination of clinical experience, academic research and systems thinking has shaped her reputation as an insightful and highly credible healthcare speaker.

Today, Rozelle is widely recognised for her expertise in healthcare AI governance and digital transformation. Through EMBLA Risk Solutions, she works to establish independent standards for clinical decision intelligence, applying Bayesian statistics and reliability engineering to determine whether AI tools are genuinely safe for clinical use. She has also contributed to an EPSRC report examining the role of digital technology in reducing unnecessary hospital admissions, focusing on what evidence-based innovation actually looks like beyond the pilot stage. Holding Clinical Safety Officer credentials under DCB0129 and DCB0160, Rozelle advises organisations on EU AI Act compliance and Software as a Medical Device regulation, helping healthcare leaders navigate increasingly complex regulatory environments. Her expertise has led to invitations to speak internationally, including appearances on the main agenda at the International MedTech Safety Conference in Boston and for AI@Cam at the Cambridge Festival of Ideas.

Event organisers value Rozelle because she combines intellectual depth with practical insight and an accessible speaking style. Her keynote talks cover subjects including dementia diagnostics, healthcare AI safety, digital innovation within the NHS, clinical decision-making and patient advocacy in a rapidly changing healthcare landscape. Rozelle is particularly respected for cutting through industry hype and presenting honest, evidence-led perspectives on what technology can and cannot achieve within healthcare. She believes innovation and safety should work together, not compete against each other, and encourages organisations to think more critically about how digital tools are introduced into clinical settings. Whether speaking to healthcare professionals, technology leaders or public audiences, Rozelle delivers informed, engaging and thought-provoking presentations that leave audiences with a clearer understanding of the future of medicine and the responsibility required to shape it well.